Trials / Sponsors / Minerva Neurosciences
Minerva Neurosciences
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of R Negative Symptoms in Schizophrenia | Phase 1 | 2023-10-13 |
| Completed | A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder Major Depressive Disorder | Phase 2 | 2018-03-30 |
| Completed | Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of Sc Negative Symptoms of Schizophrenia | Phase 3 | 2017-12-15 |
| Completed | A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Exte Healthy Subjects | Phase 1 | 2017-01-09 |
| Completed | A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy Subjects Healthy Subjects | Phase 1 | 2016-11-30 |
| Completed | Pharmacokinetic Study of MIN-101 in Healthy Subjects Schizophrenia | Phase 1 | 2014-09-01 |